How should I calculate the dose of topical corticosteroids for a child with atopic eczema using fingertip‑unit (FTU) guidelines based on the child's weight?

Calculating Topical Steroid Dose in Pediatric Atopic Eczema

Use the fingertip unit (FTU) method to calculate topical corticosteroid doses for children with atopic eczema, adjusting the number of FTUs based on the child's age and body surface area affected.

The Fingertip Unit Method

One FTU is the amount of ointment squeezed from a tube with a 5mm nozzle from the tip of the adult index finger to the first crease, covering approximately 286 cm² (about 2% body surface area in adults) 1. This standardized measurement provides an objective, practical way to prescribe and apply appropriate amounts of topical corticosteroids 2, 3.

Age-Based Dosing Guidelines

For practical prescribing, use these age-adjusted ratios 4:

• Infants (0-1 year): Require approximately one-fifth (20%) of adult doses
• Young children (1-5 years): Require approximately two-fifths (40%) of adult doses
• Pre-teens/adolescents (6-12 years): Require approximately two-thirds (67%) of adult doses

FTUs Required by Body Area in Children

Based on validated research in children aged 6 months to 9 years with atopic eczema 2, the following FTU guidelines are accurate to within 1 FTU per anatomical region:

Typical FTU Requirements by Body Region:

• Face and neck: 1-2.5 FTUs
• One arm: 1.5-3 FTUs
• One hand: 0.5-1 FTU
• Chest and abdomen: 3-7 FTUs (depending on age)
• Back: 3-7 FTUs (depending on age)
• One leg: 3-6 FTUs
• One foot: 1-2 FTUs

Practical Application Algorithm

Step 1: Identify all affected body areas requiring treatment

Step 2: Calculate total FTUs needed per application using age-appropriate values for each body region

Step 3: Determine frequency (typically once or twice daily) 5, 3

Step 4: Calculate total amount to prescribe:

• Total FTUs per application × applications per day × days of treatment
• One FTU ≈ 0.5 grams of ointment

Step 5: Prescribe appropriate potency based on location 5:

• Mild-to-moderate potency: Face, neck, flexures, genitals
• Moderate-to-potent: Trunk and extremities
• Avoid very potent/ultra-potent on thin skin areas in children

Critical Safety Considerations

Children under 6 years, especially infants, are at highest risk for hypothalamic-pituitary-adrenal (HPA) axis suppression due to their high body surface area-to-volume ratio 6. Key precautions include:

• Use the lowest effective potency for the shortest duration needed
• Limit high-potency steroids to 2-4 weeks maximum 3
• Avoid occlusion with high-potency preparations
• Monitor closely for adverse effects (striae, atrophy, telangiectasias)
• Provide clear written instructions on amount and application sites 2

Proactive Maintenance Therapy

After achieving disease control, implement proactive therapy with twice-weekly application of topical corticosteroids to previously affected areas to prevent relapses in children with moderate-to-severe atopic dermatitis 5, 7. This approach reduces flare frequency while minimizing total steroid exposure.

Common Pitfalls to Avoid

1. Under-prescribing: Studies show 35-40% of prescriptions are insufficient based on FTU calculations 8. Ensure adequate quantities are prescribed for the treatment duration.

2. Inadequate patient education: Nearly half of patients apply insufficient amounts 8. Demonstrate the FTU method visually and provide written guidance sheets 2.

3. Inappropriate potency selection: Using potent steroids on facial or intertriginous areas increases adverse effect risk 6. Match potency to anatomical location.

4. Abrupt discontinuation: Stopping high-potency steroids suddenly can cause rebound flares 6. Taper or transition to lower-potency agents or calcineurin inhibitors.

5. Ignoring body surface area: Children's BSA varies significantly with age—use age-adjusted calculations rather than adult dosing 4.